Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 5mg is intended strictly for laboratory research use only
Retatrutide shows the highest weight loss in trials (28.7%), followed by tirzepatide (25%)
The minimal side effects make the combination suitable for extended protocols without the concerns of traditional anti-inflammatory drugs
The figure printed on each batch's Certificate of Analysis reflects the purity value recorded in the laboratory for that specific batch
Despite its unlicensed status, retatrutide is increasingly being sold online often marketed as a 'research peptide' and some individuals are obtaining it outside regulated medical channels
Gallagher et al
US$ 20.03
US$ 20.44
US$ 23.29
US$ 29.16
US$ 22.52
US$ 24.60
US$ 23.19
US$ 28.76
US$ 21.56
